ARCHIVES

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

This article is from The Cancer Letter archive.

Vol. 31 No. 10 | March 11, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

July 11, 2014

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

January 31, 1992

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

January 28, 2005

Virus Program Scientific Activities Report Concluded

August 22, 1975

Society Develops Guidelines For Integrative Oncology

August 31, 2007